new molecules and indications for glp-1 medicines Emerging Frontiers in Therapeutics: A Comprehensive Evidence Base (2025) The Multifaceted Nature of GLP-1:

A recent meta-analysis involving 32,884 patients from 19 randomized controlled trials further confirmed a 23% reduction in all-cause mortality associated with GLP-1RAs use (OR = 0.77) (Rivera et al., 2024)

If you do step back and have a wide lens, it seems like this drug is literally a miracle and theres nothing it cant do, she says

Studies with treatment with GLP-1 analogues in type 2 diabetes have found that the initial postprandial insulin is increased after treatment, and this has been misinterpreted as evidence for a GLP-1 mediated insulin stimulation [28]

Regulatory Context: The telehealth weight management space has experienced significant regulatory attention in recent years

It can take up to three months for results to show